Some problems in the surgical treatment of gastric cancer

Chinese Journal of Cancer

Volumn 29, Issue 4, 2010, Pages 369-373

  Wang, Xiaona ^a,b   Liang, Han ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Cancer Research Institute   (China)

Author keywords

Gastric neoplasm; Surgery therapy

Indexed keywords

ARTICLE; CANCER INFILTRATION; CANCER STAGING; CANCER THERAPY; CLINICAL ASSESSMENT; CYSTECTOMY; EARLY CANCER; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ENDOSCOPY; EXTENDED RADICAL GASTRECTOMY; GASTRECTOMY; HUMAN; LAPAROSCOPY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; OUTCOME ASSESSMENT; PANCREATICODUODENECTOMY; PATHOLOGY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; SPLENECTOMY; STOMACH CANCER; STOMACH PERFORATION; SURVIVAL RATE; TUMOR DIFFERENTIATION;

EID: 79955839011     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10629     Document Type: Article

References (41)

1. Pan Y, Liang H, Xue Q, et al. Comparison of the prognostic value of UICC and JGCA lymph node staging criteria for gastric cancer [J]. Zhonghua Zhong Liu Za Zhi. 2008,30(5):376-380. [in Chinese]
2. Deng JY, Liang H, Dan Sun, et al. The most appropriate category of metastatic lymph nodes to evaluate overall survival of gastric cancer following curative resection [J].J Surg Oncol, 2008,98(5):343-348.
3. Wang XN, Ni SS, Liang H. Prognostic significance of metastatic lymph nodes ratio in patients with gastric cancer [J]. Zhonghua PuTong WaiKe ZaZhi. 2008,23(6):411-415. [in Chinese].
4. Wang XN, Ding XW, Liang H, et al. Correlation analysis of gastric cancer with extranodal metastasis [J] Zhonghua Wei Chang Wai Ke Za Zhi. 2007,10(5):436-439. [in Chinese]
5. Etoh T, Sasako M, Ishikawa K, et al. Extranodal metastasis is an indicator of poor prognosis in patients with gastric carcinoma[J]. Br J Surg. 2006, 93(3):369-373.
6. Oda I, Saito D, Tada M, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer [J]. Gastric Cancer, 2006, 9 (4):262-270.
7. Ishikawa S, Togashi A, Inoue M, et al. Indications for EMR /ESD in cases of early gastric cancer: relationship between histological type, depth of wall invasion, and lymph node metastasis [J].Gastric Cancer, 2007, 10 (1):35-38.
8. Lee JH, Kim JJ. Endoscopic mucosal resection of early gastric cancer: experiences in Korea [J]. World J Gastroenterol, 2007,13 (27):3657-3661.
9. Youn JC, Youn YH, Kim TI.Factors affecting longterm clinical outcomes of endoscopic mucosal resection of early gastric cancer [J]. Hepatogastroenterology, 2006, 53 (70): 643-647.
10. Uedo N, Iishi H, Tatsuta M, et al. Longterm outcomes after endoscopic mucosal resection for early gastric cancer [J]. Gastric Cancer, 2006, 9 (2):67-69.
11. Chung IK, Lee JH, Lee SH, et al. Herapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study [J]. Gastrointest Endosc. 2009,69 (7):1228-1235.
12. Kunisaki C, Shimada H, Nomura M, et al. Appropriate lymph node dissection for early gastric cancer based on lymph node metastases[J]. Surgery. 2001,129(2):153-157.
13. Shimoyama S, Yasuda H, Mafune K, et al. Indications of a minimized scope of lymphadenectomy for submucosal gastric cancer [J].Ann Surg Oncol. 2002 9 (7):625-631.
14. Shimada S, Yagi Y, Shiomori K, et al. Characterization of early gastric cancer and proposal of the optimal therapeutic strategy [J].Surgery. 2001,129(6):714-719.
15. Shen L, Huang Y, Sun M, et al. Clinicopathological features associated with lymph node metastasis in early gastric cancer: analysis of a single-institution experience in China[J]. Can J Gastroenterol. 2009,23(5):353-356.
16. Nakajima T. Gastric cancer treatment guidelines in Japan [J].Gastric Cancer, 2002, 5(1):1-5.
17. Saka M, Katai H, Fukagawa T, et al. Recurrence in early gastric cancer with lymph node metastasis[J]. Gastric Cancer. 2008,11(4):214-218.
18. Otsuji E, Kuriu Y, Ichikawa D, Prediction of lymph node metastasis by size of early gastric carcinoma [J]. Hepatogastroenterology. 2007,54(74): 602-605.
19. Kim JJ, Song KY, Hur H, et al. Lymph node micrometastasis in node negative early gastric cancer[J]. Eur J Surg Oncol. 2009,35(4):409-414.
20. Adachi Y, Kitano S, Sugimachi K. Surgery for gastric cancer: 10-year experience worldwide.[J] Gastric Cancer. 2001;4(4):166-174.
21. Desai AM, Pareek M, Nightingale PG, et al. Improving outcomes in gastric cancer over 20 years [J]. Gastric Cancer. 2004;7 (4):196-201; discussion 201-203.
22. Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group tria [J]. J Clin Oncol, 2004, 22(11):2069-2077.
23. Roukos DH, Kappas AM. Targeting the optimal extent of lymph node dissection for gastric cancer [J]. J Surg Oncol,2002, 81(2):59-62.
24. Huang CM, Lin JX, Zheng CH, et al. Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer [J]. World J Gastroenterol. 2009,15(31):3926-3930.
25. Liang H, Xue Q, Zhang RP, et al. Relationship between the dissected lymph node number and the prognosis in D (2) gastrectomy for gastric cancer[J]. Zhonghua Wei Chang Wai Ke Za Zhi. 2007 10 (6):528-530. [in Chinese]
26. Yang YD, Abuduowaili, Wushouer, et al. An investigation on the lymph node metastasis in gastric carcinoma [J]. J Xinjiang Med Univ. 2007,30 (8):824-826.
27. Zhang CH, He YL, Zhan WH, et al. Impact of spleen preservation on the outcome of radical resection for cardia cancer [J]. Zhonghua Wei Chang Wai Ke Za Zhi. 2007,10(6):531-534.[in Chinese]
28. Yoshikawa T, Sasako M, Sano T, et al. Stage migration caused by D2 dissection with paraaortic lymphadenectomy for gastric cancer from the results of a prospective randomized controlled trial[J].Br J Surg, 2006,93 (12):1526-1529
29. Allum WH, Griffin SM, Watson A, et al. Guidelines for the management of oesophageal and gastric cancer [J]. Gut, 2002, 50(Suppl 5):v1-v23.
30. Zhan WH, He YL, Zheng ZQ, et al. Effectiveness of para-aortic lymph node dissection for advanced gastric cancer [J]. Zhonghua Wai Ke Za Zhi. 2003,41(5):375-38. [in Chinese]
31. Pedrazzani C, Marrelli O, Dileo A, et al. Super-extended (D3) lymphadenectomy in advanced gastric cancer.Results from two Italian centers.8th IGCC Abstract S4,Krakow, 2009.
32. Takashi F, Nakamura K, Oyama K, et al. Selective para-aoritic lymph node dissection for gastric cancer.8th IGCC, Abstract S3, Krakow, 2009.
33. Ikeguchi M, Kaibara N. Lymph node metastasis at the splenic hilum in proximal gastric cancer[J]. Am Surg, 2004, 70 (7): 645-648.
34. Zhang CH, Zhan WH, He YL, et al. Spleen preservation in radical surgery for gastric cardiac cancer [J]. Ann Surg Oncol, 2007, 14 (4): 1312-1319.
35. Wang SB, Wang J. The argue and tendency of resection of body and tail and splenectomy or resection of head of pancreas in advanced gastric cancer[J]. Chinese Journal of Practical Surgery, 2005,25(8):462-464.
36. Zhan WH. Reasonable selection of multiorgan resection for gastric cancer and apply of pancreatoduodenectomy in advanced gastric cancer [J]. Chin J Pract Surg. 2001,21(7): 398-399. [in Chinese]
37. Hirose K, Onchi H, Iida A, et al. Surgical results of pancreaticoduodenectomy for carcinoma of the distal third of the stomach [J]. Int Surg. 1999,84(1):18-24.
38. Zhan WH. Pancreatoduodenectomy for treating advanced gastric cancer involving the pancreas and the duodenum [J]. J Surg Concepts & Pract. 2005,10(5):392-294. [in Chinese]
39. Chen JQ. Selection of extended resection for gastric carcinoma.Chin. J Gastrointest Surg. 2003,6(2):69-70. [in Chinese]
40. Saka M, Mudan SS, Katai H, et al. Pancreaticoduodenectomy for advanced gastric cancer [J]. Gastric Cancer,2005,8(1):1-5.
41. Ming XH. Surgical treatment of gastric antrum carcinoma invading the head of pancreas [J]. J TaiShan Med Coll. 2008, 9 (29):695-696. [in Chinese]